ArticleJournal of clinical immunology2014

Clinical experience with an L-proline–stabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability.

Morna J Dorsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.